Sandu Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022, to consider and approve Unaudited Financial Results of the Company for the Quarter 30th June 2022; to consider/ recommend Dividend for the Financial Year 2021-22; and any other matter with the permission of Chairman.
The above information is a part of company’s filings submitted to BSE.